Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK

American Journal of Nephrology

Volumn 31, Issue 4, 2010, Pages 363-374

  Ding, Da Fa ^a   You, Na ^a   Wu, Xiao Mei ^b   Xu, Jia Rong ^a   Hu, Ai Ping ^a   Ye, Xiao Long ^a   Zhu, Qun ^a   Jiang, Xiu Qing ^a   Miao, Heng ^a   Liu, Chao ^c   Lu, Yi Bing ^a,b  

^a THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b Department of Endocrinology   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Adenosine monophosphate activated protein kinase; Diabetic nephropathy; Eukaryotic translation initiation factor 4E binding protein 1; Hypertrophy; Phospho ribosomal protein S6; Renal mesangial cells; Resveratrol

Indexed keywords

ADENYLATE KINASE; ALBUMIN; CREATININE; GLUCOSE; INITIATION FACTOR 4E BINDING PROTEIN 1; PROTEIN S6; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DNA SYNTHESIS; DRUG EFFECT; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; KIDNEY HYPERTROPHY; MESANGIUM CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; DIABETIC NEPHROPATHIES; HYPERTROPHY; KIDNEY; MALE; PHOSPHORYLATION; PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

EID: 77949552845     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000300388     Document Type: Article

References (28)

1. Mason RM, Wahab NA: Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 2003; 14: 1358-1373.
2. Geoffroy K, Troncy L Wiernsperger N, Lagarde M, El Bawab S: Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels. FEBS Lett 2005; 579: 1249-1254.
3. Towler MC, Hardie DG: AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 2007; 16: 328-341.
4. Shaw RJ: LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol (Oxf) 2009; 196: 65-80.
5. Motoshima H, Goldstein BJ, Igata M, Araki E: AMPK and cell proliferation - AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol 2006; 574: 63-71.
6. Ruderman N, Prentki M: AMP kinase and malonyl-CoA targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 2004; 3: 340-351.
7. Lee MJ, Feliers D, Mariappan MM, Sataranatarajan K, Mahimainathan L, Musi N, Foretz M, Viollet B, Weinberg JM, Choudhury GG, Kasinath BS: A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 2007; 292: 617-627.
8. Harikumar KB, Aggarwal BB: Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 2008; 7: 1020-1035.
9. Saiko P, Szakmary A, Jaeger W, Szekeres T: Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res 2008; 658: 68-94.
10. Chan AY, Dolinsky VW, Soltys CL, Viollet B, Baksh S, Light PE, Dyck JR: Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J Biol Chem 2008; 283: 24194-24201.
11. Bortolotti C, Kunit T, Moder A , Hufnagl C, Schmidt S, Hartl A, Langelueddecke C, Fürst J, Geibel JP, Ritter M, Jakab M: The phytostilbene resveratrol induces apoptosis in INS- 1E rat insulinoma cells. Cell Physiol Biochem 2009; 23: 245-254.
12. Lee MJ, Feliers D, Sataranatarajan K, Mariappan MM, Li M, Barnes JL, Choudhury GG, Kasinath BS: Resveratrol ameliorates high glucose-induced protein synthesis in glomerular epithelial cells. Cell Signal 2010; 22: 65-70.
13. Lu Y, Liu C, Miao X, Xu K, Wu X, Liu C: Increased expression of myo-inositol oxygenase is involved in the tubulointerstitial injury of diabetic nephropathy. Exp Clin Endocrinol Diabetes 2009; 117: 257-265.
14. Matsusaka T, Xin J, Niwa S, Kobayashi K, Akatsuka A, Hashizume H: Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocytespecific injury. J Am Soc Nephrol 2005; 16: 1013-1023.
15. Kim SI, Han DC, Lee HB: Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells. J Am Soc Nephrol 2000; 11: 80-87.
16. Buga GM, Frank JS, Mottino GA, Hakhamian A, Narasimha A, Watson AD, Yekta B, Navab M, Reddy ST, Anantharamaiah GM, Fogelman AM: D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet. J Lipid Res 2008; 49: 192-205.
17. Tikoo K, Singh K, Kabra D, Sharma V, Gaikwad A: Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy. Free Radic Res 2008; 42: 397-404.
18. Sharma S, Anjaneyulu M, Kulkarni SK, Chopra K: Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology 2006; 76: 69-75.
19. Venkatesan B, Ghosh-Choudhury N, Das F, Mahimainathan L, Kamat A, Kasinath BS, Abboud HE, Choudhury GG: Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B. FASEB J 2008; 22: 3469-3482.
20. Dasgupta B, Milbrandt J: Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci USA 2007; 104: 7217-7222.
21. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA: Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003; 425: 191-196.
22. Borra MT, Smith BC, Denu JM: Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 2005; 280: 17187-17195.
23. Chen JK, Chen J, Thomas G, Kozma SC, Harris RC: S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 2009; 297: 585-593.
24. Feliers D, Duraisamy S, Barnes JL, Ghosh- Choudhury G, Kasinath BS: Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II. Am J Physiol Renal Physiol 2004; 288: 521-529.
25. Kueck A, Opipari AW Jr, Griffith KA, Tan L, Choi M, Huang J, Wahl H, Liu JR: Resveratrol inhibits glucose metabolism in human ovarian cancer cells. Gynecol Oncol 2007; 107: 450-457. (Pubitemid 350160855)
26. Haider UG, Sorescu D, Griendling KK, Vollmar AM, Dirsch VM: Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Mol Pharmacol 2002; 62: 772-777.
27. Brito PM, Devillard R, Nègre-Salvayre A, Almeida LM, Dinis TC, Salvayre R, Auge N: Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells. Atherosclerosis 2009; 205: 126-134.
28. Dolinsky VW, Chan AY, Robillard Frayne I, Light PE, Des Rosiers C, Dyck JR: Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1. Circulation 2009; 119: 1643-1652.